Egypt Herbal Supplements Market Size & Outlook, 2025-2033
Egypt Herbal Supplements Market Insights
- As highlighted in Deep Market Insights analysis, the Egypt Herbal Supplements Market, worth USD 330.39 Million in 2024, is forecasted to achieve USD 650.11 Million by 2033.
- The Egypt market is anticipated to grow at a CAGR of 7.72% during the period 2025–2033.
- By 2024, Turmeric represented the largest share of the Herb type market size.
- Turmeric is expected to remain the key growth driver within Herb type, registering the fastest CAGR during the forecast period.
Source: DMI Analysis Company Publications, Primary Interviews.
Other Key Findings
- As of 2024, Egypt held 0.83% of the global Herbal Supplements Market size.
- By 2033, United States is anticipated to capture the largest share of the global Herbal Supplements Market.
- In Middle East and Africa, United Arab Emirates is expected to lead the regional Herbal Supplements Market size by 2033.
- Saudi Arabia will remain the fastest-growing market in Middle East and Africa, reaching USD 1393.08 Million by 2033.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 330.39 Million |
| Market Size In 2033 | USD 650.11 Million |
| Largest segment | Turmeric |
| Units | Revenue in USD Million |
| CAGR | 7.72% (2025-2033) |
| Segmnetation Covered | |
| Herb type |
|
| Format |
|
| End-use |
|
| Channel |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Egypt Herbal Supplements Market Herb type 2025-2033 (USD Million)
| Herb type | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turmeric | XX.x | XX.x | XX.x | 160.9 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Echinacea | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Ginseng | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Egypt Herbal Supplements Market Format 2025-2033 (USD Million)
| Format | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Extracts | XX.x | XX.x | XX.x | 150.79 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Tablets | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Teas | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Egypt Herbal Supplements Market End-use 2025-2033 (USD Million)
| End-use | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Health | XX.x | XX.x | XX.x | 150.53 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Immune | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Digestive | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Egypt Herbal Supplements Market Channel 2025-2033 (USD Million)
| Channel | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Retail | XX.x | XX.x | XX.x | 189.12 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| E-commerce | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.